BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Novartis India Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500672
ISIN Demat
INE234A01025
Book Value (Rs)
313.912669
NSE Symbol
NOVARTIND
Divident Yield %
0
Market Cap
(Rs In Cr.)
3,109
P/E (TTM)
31.97
EPS (TTM)
39.38
Face Value
(Rs)
5
Back
Novartis India standalone net profit declines 13.82% in the March 2026 quarter
12-May-26   Hrs IST

Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales90.5583.88 8 354.33356.27 -1
OPM %22.7728.51 -26.5625.66 -
PBDT30.5634.42 -11 131.61132.61 -1
PBT30.1433.89 -11 129.66130.42 -1
NP25.2529.30 -14 93.18100.90 -8

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)